Study on Ivermectin and Cancer Outcomes

Yeah, so to be clear, this was a, you know, a purely observational

study and has lots of limitations as a result of the

nature of the way it was done. What we did is we looked at nearly

200 patients, so it was 197 of them, with many, many

different brands of cancer, and looked at how

taking the combination of ivermectin and mebendazole,

what impact that had, if any, on their cancer.

Uh, and lo and behold, what we found really was quite compelling.

84% of people had a positive...

Excuse me. Excuse me.

Excuse me.

Bad time for a sneeze.

It was that bad.

Had, uh, 84% had a positive, uh, outcome,

and meaning that 48% had either no

evidence of cancer at all at the end or

significant remission of their cancer.

Another 36% had no, uh, no

progression of their disease, and only 15% total of

these people had progression of their cancer.

Now, again, lots of limitations in a study like this.

Some people are also getting radiation.

Some people are, may or may not have been doing chemotherapy.

We have all of that data. So there were a mixture of things, but

the fact that 84% of the people taking

ivermectin and mebendazole had a positive outcome, at a minimum,

Drew, should motivate further study, should

motivate big dollars-

Right

... to be spent on a large, you know, well, you know, randomized

control trial to investigate this.

Because there's no question, we've known for decades,

ivermectin in particular has very, very powerful

anti-cancer properties, 12 different mechanisms by which it

interrupts cancer growth and progression.

Uh, it is an incredibly safe drug, great safety

profile, relatively inexpensive, and in comparison to

chemotherapy, wildly inexpensive.

And most importantly, it actually supports your immune

system rather than destroying it, which is what

typical chemother- traditional chemotherapy may kill

cancer cells, but it also kills a heck of a lot of good

stuff in the process.